Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: OTHER
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~For inclusion in the study participants must fulfill the following criteria:~* Provision of written informed consent prior to any study-specific procedures.~* Female or male aged ≥18 years at time of consent.~* Diagnosed with T2DM.~* Treatment with one or more non-insulin antihyperglycaemic medication(s) for at least 6 months prior to enrolment~* Own/have access to a smart phone with internet access and have access to the internet via a tablet or personal computer at least once a day. At the HCP's discretion, a patient may be without access to their smart phone service, data connection, and internet access for a period of time that should be ≤2 consecutive weeks~* HbA1c levels ≥8.0% and ≤11.0% within the last 6 months. If more than 1 value is available during the 6-month time period, all values must be within this range~* Body mass index (BMI) ≥25 and ≤55 kg/m2 within the last 3 months~* Ability to communicate in English~* Judged by their HCP to have suitable hearing, vision, manual dexterity, ability to understand instructions, and ability to use and understand smart phone and internet applications~* Negative pregnancy test (urine or serum) for female patients of childbearing potential~Exclusion criteria:~Participants cannot enter the study if any of the following exclusion criteria are fulfilled:~* Pregnancy~* Insulin use at baseline~* Current use of a smart phone- or web portal-based tool to help with management of T2DM~* History of type I diabetes or ketoacidosis~* Currently taking a weight loss medication~* Involvement in the planning and/or conduct of the study (applies to both AZ staff and/or staff and affiliates at the study site)~* Previous enrolment in the present study~* Participation in a clinical study with an investigational product or a disease state management program during the last 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard of Care + digital disease management cohort (Type: None): Participants will have access to the smart phone- and web portal-based digital disease management tool in addition to standard care.
- Standard of Care cohort (Type: None): Participants will have standard care with no access to the digital disease management tool.

Based on this trial design, predict the completion outcome and termination type (if applicable).